ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.326,17
0,66%
S&P 500
5.482,87
0,09%
Dow Jones
39.164,06
0,09%
Euro vs US Dollar
1,07115
0,03%
Bitcoin
61.649,19
0,06%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Nkarta Inc (NKTX)

  7. Nkarta Inc (NKTX) News

NKTX

Nkarta (NKTX)

Nkarta Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:NKTX
DatumZeitQuelleÜberschriftSymbolFirma
27/06/202412h00GlobeNewswire Inc.Nkarta Initiates Clinical Trial of NKX019 in Lupus Nephritis with First Patient in Screening and Announces Pipeline Expansion to Additional Autoimmune IndicationsNASDAQ:NKTXNkarta Inc
14/06/202422h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NKTXNkarta Inc
14/06/202422h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NKTXNkarta Inc
14/06/202422h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NKTXNkarta Inc
14/06/202422h04Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:NKTXNkarta Inc
13/06/202422h22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NKTXNkarta Inc
13/06/202422h01GlobeNewswire Inc.Nkarta Adds Experienced Leader in Autoimmune R&D, George Vratsanos, M.D., FACR, to Board of DirectorsNASDAQ:NKTXNkarta Inc
09/05/202422h14Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NKTXNkarta Inc
09/05/202422h04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NKTXNkarta Inc
09/05/202422h01GlobeNewswire Inc.Nkarta Reports First Quarter 2024 Financial Results and Corporate HighlightsNASDAQ:NKTXNkarta Inc
03/04/202422h02GlobeNewswire Inc.Nkarta to Participate in Upcoming Investor ConferencesNASDAQ:NKTXNkarta Inc
25/03/202411h30GlobeNewswire Inc.Nkarta Announces Pricing of $240 Million Underwritten OfferingNASDAQ:NKTXNkarta Inc
21/03/202421h01GlobeNewswire Inc.Nkarta Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate HighlightsNASDAQ:NKTXNkarta Inc
05/03/202422h26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NKTXNkarta Inc
01/03/202422h32Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:NKTXNkarta Inc
28/02/202414h01GlobeNewswire Inc.Nkarta to Participate in Upcoming Investor ConferencesNASDAQ:NKTXNkarta Inc
15/02/202403h12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NKTXNkarta Inc
12/02/202422h20Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:NKTXNkarta Inc
09/02/202412h38Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:NKTXNkarta Inc
18/01/202422h45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NKTXNkarta Inc
18/01/202422h43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NKTXNkarta Inc
18/01/202422h40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NKTXNkarta Inc
08/01/202422h50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NKTXNkarta Inc
08/01/202422h49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NKTXNkarta Inc
08/01/202422h48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NKTXNkarta Inc
08/01/202422h46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NKTXNkarta Inc
08/01/202414h50Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NKTXNkarta Inc
03/01/202422h15Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:NKTXNkarta Inc
10/12/202302h31GlobeNewswire Inc.Nkarta Presents NKX101 Clinical Data at the 2023 American Society of Hematology Annual Meeting & ExpositionNASDAQ:NKTXNkarta Inc
13/11/202314h25Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:NKTXNkarta Inc
 Showing the most relevant articles for your search:NASDAQ:NKTX

Kürzlich von Ihnen besucht

USOTC
PLTWF
Planet 13 (PK)
NYSE
MFC
Manulife Financial
BIT
P20CW1
NLBNPIT20CW1 20240920 33...
NASDAQ
AZYO
Aziyo Biologics
BIT
P1VEB7
NLBNPIT1VEB7 20351221 39...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten